Literature DB >> 18501447

The relation between Helicobacter pylori infection and cardiac syndrome X: a preliminary study.

Majid Assadi, Mohsen Saghari, Abdolali Ebrahimi, Mohammad Reza Pourbehi, Mohammad Eftekhari, Iraj Nabipour, Moloud Abbaszadeh, Mozhgan Nazarahari, Mozhdeh Nasiri, Sakineh Assadi.   

Abstract

Cardiac syndrome X is defined by an angina pectoris with normal or near normal coronary angiogram.We evaluated the association of Helicobacter pylori (HP) infection with cardiac syndrome X (CSX). We studied 30 patients with CSX, 30 cases with stable angina and also 30 healthy controls. All three groups underwent urea breath test (UBT). Fifty percent (15 out of 30) of CSX patients had positive UBT result (> or =200 dpm), while two other groups did not have the positive results. Regarding high prevalence of HP infection in patients with CSX in our study and probable causative effect of chronic infection in coronary artery diseases, possible role of HP infection in the pathogenesis of CSX is suggested. However well designed clinical trial studies are needed to confirm this preliminary result.

Entities:  

Mesh:

Year:  2008        PMID: 18501447     DOI: 10.1016/j.ijcard.2008.01.029

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

Review 1.  Role of Helicobacter pylori infection in pathogenesis of atherosclerosis.

Authors:  Rajesh Vijayvergiya; Ramalingam Vadivelu
Journal:  World J Cardiol       Date:  2015-03-26

2.  Association Between Helicobacter Pylori Infection and Long-term Outcome in Patients with Drug-eluting Stent Implantation.

Authors:  Rui Wang; Lei-Lei Chen; De-Zhao Wang; Bu-Xing Chen
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

3.  Helicobacter pylori Infection Maybe a Risk Factor for Cardiac Syndrome X.

Authors:  Dong-Hong Zhang; Chen Yuan; Bei-Bei Wang; Xin-Jiang Dong; Shu-Ping Lv; Fei-Hong Li; Zhen-Xiu Hou; Xiao-Li Liu; Kang Chen
Journal:  Front Cardiovasc Med       Date:  2022-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.